TechJournal South
Header

Archive for September, 2009

Wonderlic expanding in Charleston

Wednesday, September 30th, 2009

CHARLESTON, SC – Wonderlic, Inc., a company selling recruiting, assessment and retention solutions, as well as consulting services, is expanding in Charleston, South Carolina.

Headquartered in Libertyville, Illinois, the 72-year-old company has helped more than 50,000 organizations worldwide identify, select and retain qualified people.

Clients include retailers, restaurants, manufacturing firms, franchisors, professional service firms, colleges and technical schools.

Following the decision to diversify the company geographically, Wonderlic evaluated several cities in the southeast. “Charleston quickly rose to the top based on three primary factors: availability of a highly capable talent pool, demonstrated leadership in supporting knowledge-based companies, and the region’s outstanding livability,” said CEO Charles F. Wonderlic, Jr.

The expansion of Wonderlic was facilitated by the Charleston Digital Corridor. “The ability of our organization to connect Charlie Wonderlic with passionate, like-minded professionals in the Digital Corridor allowed him to experience the synergies of our knowledge based community first-hand,” said Digital Corridor Director, Ernest Andrade.

The company’s new offices are located on Daniel Island.

Baltimore’s FASgen nabs $1.4M NIH grant for obesity research

Wednesday, September 30th, 2009

BALTIMORE, MD – FASgen, Inc. has been awarded a new $1.4 million SBIR Phase II NIH grant for continued research for obesity. FASgen has for some time had extensive research into the effects of inhibition of the fatty acid biosynthesis pathway on the regulation of appetite and weight loss.

The company has developed numerous families of compounds that act on the well identified targets in the pathway.

“This grant supplements the Company’s extensive product development efforts in the metabolic disease field. The weight loss effects seen to date in preclinical in vivo experiments have applications in various indications, including obesity, diabetes, and fatty liver disease, including specifically non-alcoholic steatohepatitis,” said Susan Medghalchi, Ph.D., FASgen’s principal investigator under the grant.

FASgen is a drug development company founded in 2000 by four Johns Hopkins researchers to create new therapeutic products based on the selective inhibition of fatty acid biosynthesis. The Company has the exclusive license from Johns Hopkins to more than 15 years of research in the field.

Online: www.fasgen.com

Maryland’s RegeneRx selling $4.7M in stock

Wednesday, September 30th, 2009

BETHESDA, MD – REGENERX BIOPHARMACEUTICALS, INC. (NYSE Amex:RGN) has entered into a securities purchase agreement with new institutional investors for the sale of 4,512,195 shares of its common stock in a registered direct offering at 82 cents a share.

RegeneRx is focused on the discovery and development of novel peptides to accelerate tissue and organ repair. Currently, RegeneRx is developing three product candidates, RGN-137, RGN-259 and RGN-352 for dermal, ophthalmic, and cardiovascular tissue repair, respectively. RegeneRx is also developing RGN-457 for use in pulmonary indications such as cystic fibrosis.

Online: www.regenerx.com

DOE competition offers $1M for hydrogen storage advance

Wednesday, September 30th, 2009

WASHINGTON, DC – The U.S. Department of Energy (DOE)has launched the H-Prize competition, offering a $1 million cash award to the individual or team that creates the most advanced materials for hydrogen storage in vehicles.

The H-Prize is open to U.S. companies, U.S. citizens and legal U.S. residents, with certain restrictions. Participants must register on the H-Prize website (http://bit.ly/3TTN4D) by February 15, 2010.

“The hydrogen and fuel cell industry has come a long way in expanding the use of hydrogen from its common use as an industrial chemical in making fertilizers and cleaning gasoline. New emerging markets for materials handling and emergency power are providing real benefits – but in some technology areas innovations in materials, efficiency and cost will make those benefits even more substantial,” said Jeffrey Serfass, president of the Hydrogen Education Foundation.

“The H-Prize has the potential to unite researchers to create new advancements that will utilize domestic resources to sharply lower greenhouse gases in transportation and distributed electricity generation.”

In a competitive solicitation, the U.S. Department of Energy (DOE) selected the National Hydrogen Association’s Hydrogen Education Foundation, Technology Transition Corporation and SCRA to assist in administering the initial, pilot prize competition.

Online:www.scra.org; To register: http://bit.ly/3TTN4D

Greg Foster leaving Atlanta venture firm Noro-Moseley

Wednesday, September 30th, 2009

ATLANTA – Greg Foster is leaving Atlanta-based venture capital firm Noro-Moseley, saying it is veering away from the digital media space, his area of expertise, according to the Atlanta Business Chronicle.

Foster joined the firm 18 months ago from Turner Broadcasting System.

Foster told the Chronicle, “I’d rather be in a place that uses my skills.”

Noro-Moseley’s Managing Partner Mike Elliot told the Chonicle the firm decided to steer away from the digital space due to a lack of investment opportunities.

For the Atlanta Business Chronicle story see:

http://bit.ly/16sQB

Atlanta’s Preparis confirms $4.6M raise led by Fulcrum

Wednesday, September 30th, 2009

ATLANTA – Fulcrum Ventures announced today that they led a $4.6 million investment in Preparis Inc., the industry’s first subscription-based workforce preparedness platform.

TechJournal South reported the raise Sept. 1 (see: http://bit.ly/17R3uL).

The company says it will use the funds to expand its sales and marketing initiatives as well as accelerate product development. “Preparis is well positioned to deliver innovative preparedness products and services to businesses around the world,” said Armistead Whitney, CEO of Preparis.

“A company’s most valuable asset is its people, but much of the focus for disaster preparedness has focused on IT with little attention on human resources and the workplace.

“Adopting an enterprise-wide, highly scalable solution that prepares and protects your workforce for potential disasters from H1N1 to tornadoes to workplace violence should be a high priority for senior management who truly care about their people” said Frank X. Dalton, general partner at Fulcrum Ventures.

Online: www.preparis.com; www.fulcrumvp.com

Scale Finance expands in NC Triad

Wednesday, September 30th, 2009

WINSTON-SALEM, NC – Scale Finance, which provides professional CFO services, controller solutions, and support in raising capital to growth companies, is expanding in the Triad. The firm has named Rendell Richards to head its Triad office.

Richards, a veteran CFO and owner of CFO Options, is CFO at SourceHorizon Inc. (part-time since 2004) and director of finance at CB Richard Ellis, Charlotte, among other positions.

Richards said in a statement, ““When I considered joining forces with a larger firm I researched a number of regional and national companies.

“Scale Finance has a strong regional presence and reputation, but what sets them apart from other fractional CFO/Controller providers is their ability to execute securities transactions. A business owner who wants to raise capital or effect a merger/acquisition can find world–class capabilities within Scale Finance.”

Scale Finance now has offices in Charlotte, Raleigh/Durham, and Winston-Salem, NC.

Online: www.scalefinance.com

Microsoft’s free antivirus available now

Wednesday, September 30th, 2009

REDMOND, WASHINGTON – Microsoft Corp.’s new, free antivirus and anti malware software is available for free download.

Microsoft Security Essentials updates automatically daily.

The software will only run on Window’s systems.

It is available here:

http://www.microsoft.com/SECURITY_ESSENTIALS/

RTP-based Talecris expected to launch IPO this week

Wednesday, September 30th, 2009

RESEARCH TRIANGLE PARK, NC – Talecris Biotherapeutics Inc., which makes protein therapeutics, is expected to offer 28.9 million shares at $18 to $20 each in an initial public offering of stock this week.

The IPO is likely to be the largest of the week.

Stockholders are selling 15.8 million shares, according to the company’s filing with the U.S. Securities and Exchange Commission.

The company expects proceeds of about $515 million from the IPO.

Shareholders Cerberus Capital Managment and Ampersand Ventures will raise $300 million selling their stock, the Associated Press reports.

Maryland-based Celsion raising $7.1M in offering

Wednesday, September 30th, 2009

COLUMBIA, MD – Celsion (Nasdaq:CLSN), a biotechnology firm developing cancer, plans to raised $7.1 million by selling more than 2 million shares to institutional investors at $3.50 a share.

The company plans to use the proceeds to fund clinical development of its technology, which increases the effectiveness of cancer drugs.

The company is working to develop and commercialize more efficient, effective, targeted chemotherapeutic treatments based on its heat-activated liposomal technology. It says the technology delivers high concentrations of the drugs directly to a tumor.

Online: www.celsion.com